Analysis of patent applications of heterocyclic compounds in China Pharmaceutical University 2010-2014
10.11665/j.issn.1000-5048.20160220
- VernacularTitle:2010-2014年中国药科大学杂环化合物专利申请状况分析
- Author:
Hongxue LI
1
;
Lei ZHANG
Author Information
1. 国家知识产权局专利局专利审查协作江苏中心
- Publication Type:Journal Article
- Keywords:
heterocyclic compounds;
China Pharmaceutical University;
patents analysis;
cyclin-dependent kinase;
NO donor;
Polo-like kinase;
gambogic acid;
multidrug resistance
- From:
Journal of China Pharmaceutical University
2016;47(2):247-250
- CountryChina
- Language:Chinese
-
Abstract:
According to “2015 State of Innovation” released by Thomson Reuters, China Pharmaceutical University ranked the first in the field of heterocyclic compounds in 2010-2014 among innovation agencies in Asia. In order to fully understand the situation of the new drug research of this university, this paper analyzes its patent application from 2010 to 2014 in the field of heterocyclic compounds. The key applications were summarized. In summary, this university showed its advantage of high filings and high licensing rate in the field of heterocyclic compounds, yet with the shortcomings of low patent applications in PCT. Furthermore, suggestions have been made for the intellectual property management of this university.
